Rap1/B-Raf Signaling Is Activated in Neuroendocrine Tumors of the Digestive Tract and Raf Kinase Inhibition Constitutes a Putative Therapeutic Target

Publisher： Karger

E-ISSN： 1423-0194|85|1|45-53

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.85, Iss.1, 2007-03, pp. : 45-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis in Neuroendocrine Tumors: Therapeutic Applications

By  

Neuroendocrinology, Vol. 97, Iss. 1, 2012-04 ,pp. : 45-56

Karger

Access to resources Recommend Favorite

ENETS 2016 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update

By  

Neuroendocrinology, Vol. 103, Iss. 2, 2016-01 ,pp. : 117-118

Karger

Access to resources Recommend Favorite

ENETS 2011 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update

By  

Neuroendocrinology, Vol. 95, Iss. 2, 2011-12 ,pp. : 71-73

Karger

Access to resources Recommend Favorite

Therapeutic Monitoring of Gastroenteropancreatic Neuroendocrine Tumors: The Challenges Ahead

By  

Neuroendocrinology, Vol. 96, Iss. 4, 2012-10 ,pp. : 261-271

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors

By  

Neuroendocrinology, Vol. 95, Iss. 2, 2011-12 ,pp. : 120-134

Karger

Access to resources Recommend Favorite